Urvi M. Parikh

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Clinical Infectious Diseases(2022)10.1093/cid/ciac103

Top 6%

3.7DataRank

Top 6%115 citations

Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan +37 more

Papers

Driven by 35 papers — median percentile 94. Top paper: “Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)”.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Clinical Infectious Diseases(2022)10.1093/cid/ciac103

Top 6%

3.7DataRank

Top 6%115 citations

Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan +37 more

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

The Lancet HIV(2021)10.1016/s2352-3018(20)30304-0

N/A

2.4DataRank · unranked

111 citations

Thesla Palanee‐Phillips, Nyaradzo Mgodi, Ashley Mayo, Daniel Szydlo, Gita Ramjee +91 more

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00227-8

N/A

1.8DataRank · unranked

62 citations

Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne A. Akello, Rita Nakalega +28 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

PLoS ONE(2022)10.1371/journal.pone.0275794

N/A

0.665DataRank · unranked

18 citations

Vivian Brache, Leila Cochón, Louise A. Ouattara, Neelima Chandra, Terry A. Jacot +14 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

JCI Insight(2022)10.1172/jci.insight.163471

N/A

0.587DataRank · unranked

13 citations

Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji +15 more

Immune Status and SARS-CoV-2 Viral Dynamics

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad200

N/A

0.550DataRank · unranked

13 citations

Carlee Moser, Evgenia Aga, Judith S. Currier, David A. Wohl, Eric S. Daar +30 more

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

JCI Insight(2024)10.1172/jci.insight.186078

N/A

0.540DataRank · unranked

13 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction

Clinical Infectious Diseases(2022)10.1093/cid/ciac875

N/A

0.285DataRank · unranked

4 citations

Charles Craig, Elna van der Ryst, Ben Van Baelen, Jeremy Nuttall, Neliëtte van Niekerk +5 more

Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM

Clinical Infectious Diseases(2022)10.1093/cid/ciac804

N/A

0.121DataRank · unranked

1 citations

Elna van der Ryst, Charles Craig, Ben Van Baelen, Jeremy Nuttall, Neliëtte van Niekerk +5 more

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.25.564014

N/A

0DataRank · unranked

3 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

UNC Libraries(2023)10.17615/vptt-dg28

N/A

0DataRank · unranked

0 citations

Arzhang Cyrus Javan, Joseph J. Eron, Justin Ritz, Judith S. Currier, Prasanna Jagannathan +12 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

UNC Libraries(2023)10.17615/s90c-rs31

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Paul Klekotka, James P. Flynn, Joseph J. Eron, Justin Ritz +23 more

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae371

N/A

0DataRank · unranked

13 citations

Sydney I. Ramirez, Hallie Cohn, Urvi M. Parikh, Amy Heaps, Scott F. Sieg +22 more

First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae468

N/A

0DataRank · unranked

9 citations

Monica Gandhi, Elias K. Halvas, Hideaki Okochi, Carolyn Chu, David V. Glidden +18 more

Long-acting preexposure prophylaxis: early data on roll-out in the United States

Current Opinion in HIV and AIDS(2024)10.1097/coh.0000000000000894

N/A

0DataRank · unranked

5 citations

Urvi M. Parikh, Catherine A. Koss

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

Pathogens and Immunity(2024)10.20411/pai.v9i2.718

N/A

0DataRank · unranked

2 citations

Manish C. Choudhary, Amy Heaps, Rinki Deo, Daniela Moïsi, Kelley C. Gordon +12 more

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.

Pathogens and Immunity(2024)10.20411/pai.v9i2.715

N/A

0DataRank · unranked

1 citations

Amy Heaps, Daniela Moïsi, Kelley C. Gordon, John W. Mellors, Manish C. Choudhary +11 more

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment

UNC Libraries(2024)10.17615/3zpn-mj26

N/A

0DataRank · unranked

1 citations

Jonathan Z. Li, Manish C. Choudhary, Davey M. Smith, Carlee Moser, John W. Mellors +12 more

Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

UNC Libraries(2024)10.17615/8rka-bh50

N/A

0DataRank · unranked

1 citations

Sharon A. Riddler, Edward Livant, Arendevi Pather, Francis Martinson, Felix Muhlanga +9 more

HIV‐1 testing in the context of expanding PrEP modalities

Journal of the International AIDS Society(2025)10.1002/jia2.26491

N/A

0DataRank · unranked

6 citations

Jana L. Jacobs, Njambi Njuguna, Kristine Torjesen, John W. Mellors, Urvi M. Parikh

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(25)00162-6

N/A

0DataRank · unranked

3 citations

Caitlyn McCarthy, Carole L. Wallis, Cissy Kityo, Michael D. Hughes, Catherine Godfrey +44 more

Early Virologic Success on Antiretroviral Therapy Among Individuals With Breakthrough HIV Acquisition on Long-Acting Cabotegravir Pre-exposure Prophylaxis

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf285

N/A

0DataRank · unranked

1 citations

Monica Gandhi, Jessica Altamirano, Hussein Safa, Aniruddha Hazra, Lisa Georgetti Gomez +13 more

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf270

N/A

0DataRank · unranked

1 citations

Caitlyn McCarthy, Serena P. Koenig, Michael D Hughes, Carole L. Wallis, Isaac Tsikhutsu +41 more

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Clinical Infectious Diseases(2021)10.1093/cid/ciab072

N/A

0DataRank · unranked

140 citations

William Bain, Jana L. Jacobs, Sham Nambulli, Urvi M. Parikh, Anthony R. Cillo +28 more

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf645

N/A

0DataRank · unranked

0 citations

Jessica M. Fogel, Mark A. Marzinke, Elias K. Halvas, Urvi M. Parikh, John W. Mellors +15 more

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis

medRxiv(2021)10.1101/2021.06.28.21259576

N/A

0DataRank · unranked

24 citations

Mounzer Agha, Amy Lukanski, Kelsey Linstrum, Rachel Troyan, Andrew Bilderback +27 more

Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy

medRxiv(2021)10.1101/2021.09.03.21263105

N/A

0DataRank · unranked

21 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +23 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac618

N/A

0DataRank · unranked

14 citations

Jonathan Z. Li, Joseph J. Eron, Evgenia Aga, Eric S. Daar, David A. Wohl +29 more

Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention

Polymers(2022)10.3390/polym14061196

N/A

0DataRank · unranked

7 citations

Sravan Kumar Patel, Jing Li, Dorothy L. Patton, Elaine Xu, Peter L. Anderson +6 more

Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes(2022)10.1097/qai.0000000000003023

N/A

0DataRank · unranked

0 citations

Leila E. Mansoor, Dvora Joseph Davey, Thesla Palanee‐Phillips, Jennifer Smit, Khatija Ahmed +11 more

An assessment of Nano-RECall: Interpretation of Oxford Nanopore sequence data for HIV-1 drug resistance testing

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.22.501121

N/A

0DataRank · unranked

0 citations

Trevor Ngobeni, Conan K. Woods, Carli Gordijn, Mathilda Claassen, Urvi M. Parikh +3 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

UNC Libraries(2022)10.17615/473v-1p84

N/A

0DataRank · unranked

0 citations

Urvi M. Parikh, Judith S. Currier, Shane Crotty, Carlee Moser, Alessandro Sette +14 more

Nano‐RECall provides an integrated pipeline for HIV‐1 drug resistance testing from Oxford Nanopore sequence data

Tropical Medicine & International Health(2023)10.1111/tmi.13851

N/A

0DataRank · unranked

9 citations

Trevor Ngobeni, Conan K. Woods, Carli Gordijn, Mathilda Claassen, Urvi M. Parikh +3 more

Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad278

N/A

0DataRank · unranked

1 citations

Ghady Haidar, Asma Naqvi, Kevin D. McCormick, Michele D. Sobolewski, Benjamin R. Treat +17 more

Urvi M. Parikh

Indexed papers

Top data-sharing exemplar

Papers